NCT00580203Completed
Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers
Collection of Tissue, Blood, and Other Specimens From Patients With Head and Neck Diseases to Study the Causes, Diagnosis, Prevention and Treatment of Cancers
Source: ClinicalTrials.gov · Last updated 15 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is a protocol to collect tissues, blood, and other specimens from patients with malignant or nonmalignant diseases of the head and neck. Collected specimens will be used in laboratory studies to investigate the growth, development, and transformation of normal and abnormal cells in the future.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1468 (actual)
- First submitted
- 19 Dec 2007
- Start date
- 1 Feb 2004
- Primary completion date
- 12 Nov 2024
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Diseases
- Childhood cancers, Sarcoma
- NCT number
- NCT00580203
What you commit to
- Study type: Observational
- Participants enrolled: 1468
- From 1 Feb 2004 to the primary completion date, 12 Nov 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients not giving informed consent will be excluded.
Who the study is looking for
- Patients with head and neck diseases are eligible if they have had tissue, serum, urine, or other specimens removed or collected for diagnostic or therapeutic purposes.
- Patients will be entered onto this protocol without preference for any racial or ethnic group.
- Patients may have received prior chemotherapy, radiation, surgical therapy, immunotherapy, or differentiation therapy.
- The specimen collected must be large enough to allow conventional testing necessary for patient care, with the portion of the specimen reserved for research laboratory analysis excised from residual tissue that would otherwise have been discarded.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Memorial Sloan-Kettering Cancer Center Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.